Basic Information
Camel-IDS is a biotechnology company developing targeted radiopharmaceutical solutions for cancer. Its products are based on recombinant small antigen-binding fragments derived from Camelids' heavy-chain-only antibodies, combined with therapeutic radioisotopes.
Camel-IDS
Belgium
unclear
January 01, 2014
--
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios